Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

NCT00981214 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis
Exocrine Pancreatic Insufficiency

Interventions

DRUG: EUR-1008 (APT-1008)

Sponsor

Forest Laboratories